SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-20-000039
Filing Date
2020-08-06
Accepted
2020-08-06 07:17:12
Documents
17
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20200806.htm   iXBRL 8-K 51951
2 EX-99.1 ex991-q2x2020.htm EX-99.1 1051936
3 EX-99.2 ex992-q2x2020.htm EX-99.2 29219
9 GRAPHIC image211.jpg GRAPHIC 7860
  Complete submission text file 0000885590-20-000039.txt   1351445

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20200806.xsd EX-101.SCH 2439
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20200806_cal.xml EX-101.CAL 726
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20200806_def.xml EX-101.DEF 1662
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20200806_lab.xml EX-101.LAB 25240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20200806_pre.xml EX-101.PRE 13191
10 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20200806_htm.xml XML 11408
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 201079801
SIC: 2834 Pharmaceutical Preparations